Showing 1 - 4 of 4
The present paper aims to analyze industrial strategies (involving biotechnology and pharmaceutical firms) in the context of oncology where the toxicity of chemotherapies used for cancer management make the development of pharmacogenomic testing particularly relevant, considering the possibility...
Persistent link: https://www.econbiz.de/10011020463
Persistent link: https://www.econbiz.de/10007911272
Persistent link: https://www.econbiz.de/10009137626
Persistent link: https://www.econbiz.de/10003627016